Table 2.
All HPIV | LRTI | |||
---|---|---|---|---|
Factor | Risk ratio (95% CI) |
P-value | Risk ratio (95% CI) |
P-value |
Donor type | ||||
Autologous | Ref | Ref | ||
UCB | 1.4 (0.8-2.5) | 0.31 | 2.4 (1.0-6.1) | 0.06 |
Matched related | 0.9 (0.6-1.6) | 0.80 | 1.4 (0.6-3.2) | 0.41 |
Matched unrelated | 2.0 (1.1-3.7) | 0.03 | 2.3 (0.8-6.0) | 0.11 |
Mismatched related | 3.2 (1.6-6.3) | < 0.01 | 7.0 (2.7-18.3) | < 0.01 |
Mismatched unrelated | 1.3 (0.6-2.7) | 0.55 | 0.9 (0.3-3.8) | 0.98 |
Gender | ||||
Male | Ref | Ref | ||
Female | 0.9 (0.7-1.3) | 0.75 | 0.6 (0.3-1.0) | 0.04 |
Diagnosis category | ||||
Lymphoid/malignant | 1.2 (0.8-1.8) | 0.46 | 1.0 (0.5-1.9) | 0.89 |
Myeloid/malignant | Ref | Ref | ||
Non-malignant | 1.1 (0.7-1.8) | 0.66 | 0.9 (0.4-2.1) | 0.89 |
CMV | ||||
R+ | 1.0 (0.7-1.5) | 0.80 | 1.5 (0.9-2.5) | 0.15 |
R−/D− | Ref | Ref | ||
R−/D+ | 0.9 (0.4-1.7) | 0.66 | 1.2 (0.5-3.2) | 0.66 |
Unknown | 2.1 (0.6-6.9) | 0.22 | 0.0 (0.0-0.0) | 0.98 |
Age | ||||
Age < 10 years | 0.8 (0.5-1.3) | 0.42 | 0.6 (0.3-1.3) | 0.18 |
Age 10-19 | 0.5 (0.3-0.9) | 0.03 | 0.5 (0.2-1.1) | 0.07 |
Age ≥ 20 | Ref | Ref | ||
Transplant Era | ||||
1974-1992 | 0.8 (0.5-1.4) | 0.56 | 0.8 (0.4-1.6) | 0.47 |
1993-2001 | 0.7 (0.3-1.8) | 0.48 | 0.9 (0.5-1.7) | 0.71 |
2002-2010 | Ref | Ref | ||
RIC (risk < 30 days) | 0.7 (0.3-1.8) | 0.48 | 0.5 (0.1-1.9) | 0.54 |
RIC (risk ≥ 30 days) | 2.1 (1.2-3.5) | 0.01 | 1.4 (0.6-3.1) | 0.42 |
Acute GVHD | 1.9 (1.1-3.4) | 0.03 | 2.1 (0.8-5.3) | 0.11 |
Chronic GVHD | 6.2 (3.7-10.4) | < 0.01 | 7.1 (3.4-14.8) | < 0.01 |
Abbreviations: GVHD, graft-versus-host disease; Ref, reference group for each comparison category; RIC; reduced intensity conditioning; UCB, umbilical cord blood